Related Experiment Video
Updated: Feb 1, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
[Abstract - Update Arterial Hypertension 2018]
Martin Hausberg1, Bernd Sanner2
1Medizinische Klinik I, Städtisches Klinikum Karlsruhe.
Abstract:
Inadequate blood pressure measurement is among the main reasons for poor blood pressure control and misclassification of patients with normal or increased blood pressure. 24-hour ambulatory blood pressure measurement has the best predictive value for cardiovascular mortality, and it could be shown that those with masked hypertension (normal office blood pressure values but hypertensive values with 24-hour measurement) are especially at risk. An increased blood pressure variability seems to be a risk factor for the development of dementia and also raises the cardiovascular risk after TIA and minor stroke. Several new guidelines recommend lower target blood pressure values for most of the patients.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Radical Formation: Abstraction
Even though homolysis produces radicals, it is different from radical...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

